VT News

Susan Stephen

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • 3M beats expectations, raises 2025 guidance, and sees strong growth in China, but PFAS litigation remains a concern.
  • Sportsbooks offer enticing NBA opening-week bonuses to attract bettors for marquee matchups like Spurs vs. Mavericks.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • 3M beats expectations, raises 2025 guidance, and sees strong growth in China, but PFAS litigation remains a concern.
  • Sportsbooks offer enticing NBA opening-week bonuses to attract bettors for marquee matchups like Spurs vs. Mavericks.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Susan Stephen

Top Topics

Trending in U.S.

World

Sport